Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment

Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment

Candice Yong,1 M Janelle Cambron-Mellott,2 Brian Seal,1 Oliver Will,2 Martine C Maculaitis,2 Kelly Clapp,2 Emily Mulvihill,2 Ion Cotarla,1 Ranee Mehra3 1AstraZeneca, Gaithersburg, MD, USA; 2Cerner Enviza, Malvern, PA, USA; 3University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimo...

Full description

Bibliographic Details
Main Authors: Yong C, Cambron-Mellott MJ, Seal B, Will O, Maculaitis MC, Clapp K, Mulvihill E, Cotarla I, Mehra R
Format: Article
Language:English
Published: Dove Medical Press 2022-01-01
Series:Patient Preference and Adherence
Subjects:
immune checkpoint inhibitors
metastases
non-small-cell lung carcinomas
overall survival
patient preference
toxicities
Online Access:https://www.dovepress.com/patient-and-caregiver-preferences-for-first-line-treatments-of-metasta-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/patient-and-caregiver-preferences-for-first-line-treatments-of-metasta-peer-reviewed-fulltext-article-PPA

Similar Items